Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Deloitte
Johnson and Johnson
US Army
Baxter
Covington
Moodys
Cantor Fitzgerald
Accenture

Generated: December 14, 2018

DrugPatentWatch Database Preview

Jiangsu Hengrui Med Company Profile

« Back to Dashboard

What is the competitive landscape for JIANGSU HENGRUI MED, and what generic and branded alternatives to JIANGSU HENGRUI MED drugs are available?

JIANGSU HENGRUI MED has twelve approved drugs.

There is one tentative approval on JIANGSU HENGRUI MED drugs.

Summary for Jiangsu Hengrui Med

Drugs and US Patents for Jiangsu Hengrui Med

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jiangsu Hengrui Med DOCETAXEL docetaxel INJECTABLE;INJECTION 203170-001 Feb 15, 2017 RX No Yes ➤ Sign Up ➤ Sign Up
Jiangsu Hengrui Med THIOTEPA thiotepa INJECTABLE;INJECTION 209150-001 May 4, 2018 AP RX No No ➤ Sign Up ➤ Sign Up
Jiangsu Hengrui Med OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 203869-001 Jun 18, 2014 AP RX No No ➤ Sign Up ➤ Sign Up
Jiangsu Hengrui Med DOCETAXEL docetaxel INJECTABLE;INJECTION 207252-002 Aug 9, 2017 AP RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
QuintilesIMS
Citi
Johnson and Johnson
Healthtrust
AstraZeneca
Medtronic
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.